Innate Pharma
IPHA
#9080
Rank
C$0.17 B
Marketcap
C$1.78
Share price
0.00%
Change (1 day)
-30.50%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Innate Pharma CIK: 0001598599
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Innate Pharma only files 20-F reports

Thumbnail Innate Pharma
 20-F Annual Report 2024

20-F Annual Report 2024

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2021

20-F Annual Report 2021

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2020

20-F Annual Report 2020

Language: English

View Annual Report (20-F)
Thumbnail Innate Pharma
 20-F Annual Report 2019

20-F Annual Report 2019

Language: English

View Annual Report (20-F)